The H4 histamine receptor agonist, clobenpropit, suppresses human cholangiocarcinoma progression by disruption of epithelial mesenchymal transition and tumor metastasis-Reference-Cited by-同舟云学术

The H4 histamine receptor agonist, clobenpropit, suppresses human cholangiocarcinoma progression by disruption of epithelial mesenchymal transition and tumor metastasis

Published:2011-10-28 Issue:5 Volume:54 Page:1718-1728
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Meng Fanyin,Han Yuyan,Staloch Dustin,Francis Taylor,Stokes Allison,Francis Heather

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.24573/fullpdf

Reference41 articles.

1. Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy;Sirica;HEPATOLOGY,2005

2. Cholangiocarcinoma: a compact review of the literature;Ustundag;World J Gastroenterol,2008

3. Detection of distant metastasis to skeletal muscle by (18)F-FDG-PET in a case of intrahepatic cholangiocarcinoma;Park;Korean J Hepatol,2010

4. Histamine receptors and cancer pharmacology;Medina;Br J Pharmacol,2010

5. Histamine in cancer: the dual faces of the coin;Cianchi;Cancer Biol Ther,2008

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathophysiological role of histamine signaling and its implications in glioblastoma;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. Expression profile of messenger and micro RNAs related to the histaminergic system in patients with five subtypes of breast cancer;Frontiers in Oncology;2024-08-29

3. The story of clobenpropit and CXCR4: can be an effective drug in cancer and autoimmune diseases?;Frontiers in Pharmacology;2024-07-12

4. The Tumor Immune Microenvironment plays a Key Role in Driving the Progression of Cholangiocarcinoma;Current Cancer Drug Targets;2024-07

5. H2 antihistamines: May be useful for combination therapies in cancer?;Biochemical Pharmacology;2024-05